AKR1C1/2 inhibition by MPA resensitizes platinum resistant ovarian cancer towards platinum-based chemotherapy

Authors :: Sven Mahner
Fabian Trillsch
Bastian Czogalla
Alexander Burges
Susann Badmann
Elisa Schmoeckel
D Mayr
Udo Jeschke
S Beyer
Theresa M. Kolben
Anna Hester
Source :: Geburtshilfe und Frauenheilkunde.
Publication Year :: 2020
Publisher :: © 2020. Thieme. All rights reserved., 2020.

Subjects :: Chemotherapy
Chemistry
AKR1C1
medicine.medical_treatment
medicine
Cancer research
chemistry.chemical_element
Platinum
Ovarian cancer
medicine.disease
Platinum resistant

Tools